Trials / Conditions / Immune Effector Cell Associated Neurotoxicity Syndrome
Immune Effector Cell Associated Neurotoxicity Syndrome
6 registered clinical trials studyying Immune Effector Cell Associated Neurotoxicity Syndrome — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Assessing DCog Short for Neurotoxicity in CAR-T NCT07403812 | Beth Israel Deaconess Medical Center | N/A |
| Recruiting | Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy NCT07390071 | University of Utah | N/A |
| Not Yet Recruiting | Pre-emptive Anakinra for Cytokine Event Reduction NCT06703216 | Ann & Robert H Lurie Children's Hospital of Chicago | Phase 1 / Phase 2 |
| Recruiting | Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the O NCT06706102 | Centre Hospitalier Universitaire de Saint Etienne | Phase 4 |
| Withdrawn | Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM NCT06352866 | Jack Khouri, MD | Phase 2 |
| Recruiting | Biomarker and Imaging Package Study in Immune Effector Cell-Associated Neurotoxicity Syndrome NCT05643092 | zhang shoulong | — |